I spent 3 days with America’s biohackers — the secrets they swear weren’t what I expected

I’m talking genuinely, chronically ill. Mysterious symptoms kept me home from school and bouncing between specialists who ...
FiercePharma

ASCO: Sac-TMT’s massive phase 3 program has a jarring gap. Does Merck plan to close it?

Merck & Co.’s extensive clinical development scheme for its TROP2 antibody-drug conjugate (ADC) sac-TMT already includes 17 global phase 3 trials. But there’s one important missing piece. The New ...
Variety

‘Dutton Ranch’ Episode 3: Rip’s Cattle Might Be Ruined by Anti-Vaxxers and Carter Avoids Getting Murdered After Peeing on a Truck

SPOILER ALERT: This post contains spoilers from the third episode of “Dutton Ranch,” “Act of God Business,” which is now streaming on Paramount+. After last week’s pair of series premiere episodes, we ...
WRIC

Virginia set to rollout paid family and sick leave program in 2028

PORTSMOUTH, Va. (WAVY) — Starting at the end of 2028, Virginia will rollout a paid family and sick leave program, as announced by Governor Abigail Spanberger’s office. The governor expressed that this ...
People

Sick Toddler Ended Up in a Coma After Being Sent Home from the ER. He's Being Taken Off Life Support on Friday

The parents of a 1-year-old who was in a coma for three months were told their son's life support would be terminated GoFunMe A toddler who was sent home from the emergency room with a diagnosis of ...
Telegraph Herald

Loras to partner with Wisconsin college on 3+3 law program

Facebook Twitter WhatsApp SMS Email Print Copy article link Save Facebook Twitter WhatsApp SMS Email Print Copy article link Save Purchase Article Reprint Dubuque's Loras College will partner with a ...
Racer

McLaughlin sees potential for the No. 3 car program after second-place finish

Scott McLaughlin qualified on pole for last year’s race at St. Petersburg and finished fourth. On his return to the Floridian street course, the Team Penske driver captured pole once more and finished ...
BioSpace

Kailera Therapeutics Announces First Participants Randomized in KaiNETIC Global Phase 3 Clinical Program of GLP-1/GIP Receptor Dual Agonist Ribupatide (KAI-9531)

– Ribupatide (KAI-9531) aims to address critical need for greater weight loss, especially for people living with a BMI of 35 kg/m 2 or greater – – KaiNETIC program includes three Phase 3 clinical ...
FierceBiotech

Patient deaths prompt partial hold for Daiichi-Merck's global phase 3 ADC program

Daiichi Sankyo and Merck & Co.’s phase 3 program for their investigational antibody-drug conjugate has been hit with a hold after an unexpected number of deaths were reported in the global trial. “Due ...